Cargando...
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Targeting the amyloid‐β (Aβ) peptide cascade has been at the heart of therapeutic developments in Alzheimer's disease (AD) research for more than 25 years, yet no successful drugs have reached the marketplace based on this hypothesis. Nevertheless, the genetic and other evidence remains strong,...
Guardado en:
| Publicado en: | Br J Pharmacol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715594/ https://ncbi.nlm.nih.gov/pubmed/30710367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14593 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|